Keyword Connections

meropenem

Journals

0

No Journal Connected

Research Groups

0

No Research Group Connected

Bibliographies

21

1 Citywide Clonal Outbreak of Multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: The Preantibiotic Era Has Returned

2 resistensi <em>klebsiella</em> sp terhadap meropenem di rsud prof. dr. margono soekarjo purwokerto

3 Morphological changes induced by imipenem and meropenem at sub-inhibitory concentrations in Acinetobacter baumannii

4 Effects of sub-inhibitory concentrations of meropenem and tigecycline on the expression of genes regulating pili, efflux pumps and virulence factors involved in biofilm formation by Acinetobacter baumannii

5 Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant Enterobacteriaceae

6 Synergy effect of meropenem-based combinations against Acinetobacter baumannii: a systematic review and meta-analysis

7 Effects of sub-inhibitory concentrations of meropenem and tigecycline on the expression of genes regulating pili, efflux pumps and virulence factors involved in biofilm formation by Acinetobacter baumannii

8 Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant Enterobacteriaceae

9 Synergy effect of meropenem-based combinations against Acinetobacter baumannii: a systematic review and meta-analysis

10 Successful Clearance of Persistent Methicillin-Resistant Bacteremia with Daptomycin, Linezolid, and Meropenem Salvage Therapy.

11 Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI).

12 Spectral signal processing approaches for selective quantification of the recently FDA approved brand-new combination of Vaborbactam and Meropenem; for conformity assessment of bulk and batch release

13 Dithiocarbamates: Efficient metallo-β-lactamase inhibitors with good antibacterial activity when combined with meropenem.

14 transfer of meropenem in the ex vivo human placenta perfusion model

15 metallo-β-lactamase-production in meropenem-susceptible pseudomonas aeruginosa isolates: risk for silent spread

16 Performance of the EUCAST disc diffusion method and two MIC methods in detection of Enterobacteriaceae with reduced susceptibility to meropenem: the NordicAST CPE study

17 Fluoroquinolone Prophylaxis Selects for Meropenem-nonsusceptible Pseudomonas aeruginosa in Patients With Hematologic Malignancies and Hematopoietic Cell Transplant Recipients

18 resistensi klebsiella sp terhadap meropenem di rsud prof. dr. margono soekarjo purwokerto

19 Optimization of antibiotics for cystic fibrosis pulmonary exacerbations due to highly resistant nonlactose fermenting Gram negative bacilli: Meropenem-vaborbactam and cefiderocol

20 Individual meropenem epithelial lining fluid and plasma PK/PD target attainment.

21 Individual target pharmacokinetic/pharmacodynamic attainment rates among meropenem-treated patients admitted to the ICU with hospital-acquired pneumonia.